Canton Strategic Holdings, Inc. Common Stock CNTN Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Operating Income by Business | ||||||
| Clinical Stage Bio Technology | -$1.65M— | —— | —— | —— | -$2.55M+18.1% | |
| Digital Asset Treasury | -$35.22M-4,995% | -$691.32K0.0% | -$691.32K0.0% | -$691.32K0.0% | -$691.32K— | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest by Business | ||||||
| Clinical Stage Bio Technology | -$1.65M— | —— | —— | —— | -$2.54M+16.6% | |
| Digital Asset Treasury | -$49.92M-707% | -$6.19M0.0% | -$6.19M0.0% | -$6.19M0.0% | -$6.19M— | |
| Total Assets by Business | ||||||
| Clinical Stage Bio Technology | $1.66M-68.1% | $5.18M— | —— | —— | —— | |
| Digital Asset Treasury | $583M+13.4% | $513.96M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Canton Strategic Holdings, Inc. Common Stock break its business down?
- Canton Strategic Holdings, Inc. Common Stock (CNTN) reports operating income by business across 2 parts — Clinical Stage Bio Technology and Digital Asset Treasury. Each is extracted from the segment footnotes and tracked over time.
- Where does Canton Strategic Holdings, Inc. Common Stock's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Canton Strategic Holdings, Inc. Common Stock's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.